Adage Capital Partners
CLCD

Adage Capital Partners’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Adage Capital Partners’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-300,000
Closed -$10.9M – 784
2016
Q4 		$10.9M Hold
300,000
– – 0.03% 515
2016
Q3 		$11.4M Buy
+300,000
New +$4.43M 0.03% 500

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Adage Capital Partners's CLCD Position: Q1 2017 in Review

Adage Capital Partners sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 300,000 shares — an estimated $10.9M sold.

Adage Capital Partners first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $11.4M in Q3 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • Adage Capital Partners reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Adage Capital Partners sold 300,000 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $10.9M.
  • Adage Capital Partners first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
  • Adage Capital Partners's CoLucid Pharmaceuticals, Inc. position peaked at $11.4M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Adage Capital Partners's 13F filing for Q1 2017, filed 15 May 2017.